Callan Family Office LLC Makes New $538,000 Investment in Humana Inc. $HUM

Callan Family Office LLC purchased a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,355 shares of the insurance provider’s stock, valued at approximately $538,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Heartland Advisors Inc. bought a new position in shares of Humana during the second quarter worth about $11,770,000. Paralel Advisors LLC boosted its holdings in Humana by 31.8% in the second quarter. Paralel Advisors LLC now owns 13,322 shares of the insurance provider’s stock valued at $5,292,000 after acquiring an additional 3,212 shares during the last quarter. Allworth Financial LP acquired a new stake in Humana during the 2nd quarter valued at approximately $699,000. B. Metzler seel. Sohn & Co. AG acquired a new stake in Humana during the 2nd quarter valued at approximately $3,189,000. Finally, Trillium Asset Management LLC bought a new position in Humana during the 2nd quarter worth approximately $508,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent analyst reports. Zacks Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. lifted their target price on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 price target on shares of Humana in a research report on Wednesday, June 3rd. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Finally, Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective for the company in a research report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $403.91.

Humana Price Performance

Shares of NYSE:HUM opened at $388.92 on Wednesday. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The stock’s 50 day moving average is $383.88 and its 200-day moving average is $285.00. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $46.70 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue was up 26.2% compared to the same quarter last year. During the same quarter last year, the firm posted $6.27 EPS. Sell-side analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.